Resistance of Haemonchus sp. to monepantel and reduced efficacy of a derquantel / abamectin combination confirmed in sheep in NSW, Australia.
Early in 2015, sheep in a summer rainfall area of NSW, Australia, displayed signs of haemonchosis despite treatment with monepantel. A faecal egg count reduction test (FECRT) was performed on yearlings with natural field infections using various anthelmintics. Only a four-way combination drench achieved a reduction in faecal egg count (FEC) greater than 95%. The combination contained abamectin, albendazole, levamisole and closantel. Treatments with a derquantel/abamectin combination, monepantel and moxidectin reduced FECs by 93, 31, and 30% respectively. Sheep treated with abamectin displayed an increase in FEC of 22%. Larval differentiation counts conducted 10days post-treatment showed that 100% of survivors were Haemonchus sp. This result confirms for the first time monepantel resistant Haemonchus in sheep in NSW, and is amongst the first of the Australian cases in sheep not associated with goats. A second FECRT was performed using sheep from the moxidectin and abamectin treatment groups in the first FECRT. In this second FECRT, monepantel treatment reduced FECs by 51% and 29% in the sheep previously treated with moxidectin and abamectin respectively. This suggests monepantel, in combination with moxidectin, may give some control against severely abamectin resistant Haemonchus.
NSW DPI, Elizabeth Macarthur Agricultural Institute, Private Bag 4008, Narellan, NSW 2567, Australia. Electronic address: narelle.sales@dpi.nsw.gov.au.
Narelle
N
Sales
NSW DPI, JSF Barker Bldg., University of New England, Trevenna Road, Armidale, NSW 2351, Australia.
Stephen
S
Love
D015766:Albendazole / Q000494:pharmacology; D000607:Aminoacetonitrile / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology*; D001315:Australia; D004359:Drug Therapy, Combination; D005243:Feces / Q000469:parasitology; D006188:Haemonchiasis / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary*; D006189:Haemonchus / Q000187:drug effects*; D007211:Indoles / Q000494:pharmacology; D007559:Ivermectin / Q000031:analogs & derivatives / Q000494:pharmacology; D018942:Macrolides / Q000494:pharmacology; D008297:Male; D010082:Oxepins / Q000494:pharmacology; D010270:Parasite Egg Count / Q000662:veterinary; D011897:Random Allocation; D012458:Salicylanilides / Q000494:pharmacology; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy / Q000469:parasitology*; D017211:Treatment Failure
D000871:Anthelmintics; D007211:Indoles; D018942:Macrolides; D010082:Oxepins; D012458:Salicylanilides; C575297:derquantel; D000607:Aminoacetonitrile; C048324:abamectin; D007559:Ivermectin; C533978:monepantel; C023342:closantel; D015766:Albendazole; C027837:moxidectin
Australia; Derquantel; Haemonchus; Monepantel; Resistance; Sheep